Skip to main content
SpringerLink
Log in

Perioperative Beta-Blockade, the Pros and Cons. The Story of Beta-Blockade and Cardiac Protection

  • Chapter
  • First Online:
Perioperative Medicine – Current Controversies

  • 1468 Accesses

Abstract

Once considered to confer cardiac protection, perioperative beta-blockade is now regarded as potentially harmful as reduction of cardiac complications is associated with increased all-cause mortality and increased risk of strokes. Over the past decades relatively small studies were not powered enough to detect relatively rare complications, thus all-cause mortality and increased risk of stroke never reached statistical significance, and were discounted. It needed a large randomised controlled trial (RCT) POISE with more than 8,000 patients for these clinically important complications to reach statistical significance. POISE did not address the issue of acute goal-directed administration of beta-blockers when clinically indicated for the management of cardiovascular instability, such as tachycardia, hypertension, myocardial ischaemia, thus practice needs not change. However, initiating beta-blockade for cardiac protection needs to consider the balance of risk and benefits for each individual patient. With considerable caution in respect of beta-blockers, other pharmacological agents need to be considered. While showing promise in previous relatively small studies, clonidine and aspirin have been found in POISE 2, a RCT with over 10,000 patients, to offer no cardiac protection. Clonidine caused hypotension and aspirin increased bleeding. There is limited data and evidence for cardiac protection in respect of calcium channel blockers, ACE inhibitors, angiotensin receptor antagonists and nitroglycerin. However, observational studies and limited RCTs, mostly in cardiac surgery, suggest that statins offer perioperative protection and should be initiated in patients who need them for medical reasons.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mangano DT, Layug EL, Wallace A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335(23):1713–1720

    Article  CAS  PubMed  Google Scholar 

  2. Poldermans D, Boersma E, Bax JJ, Thomson IR, van-de-Ven LL, Blankensteijn JD et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341(24):1789–1794

    Article  CAS  PubMed  Google Scholar 

  3. Palda VA, Detsky AS (1997) Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 127(4):313–328

    Article  CAS  PubMed  Google Scholar 

  4. Devereaux PJ, Beattie WS, Choi PT, Badner NH, Guyatt GH, Villar JC et al (2005) How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 331(7512):313–321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM et al (2006) Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 152(2):223–230

    Article  CAS  PubMed  Google Scholar 

  6. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371(9627):1839–1847

    Article  CAS  PubMed  Google Scholar 

  7. Viljoen JF, Estafanous FG, Kellner GA (1972) Propranolol and cardiac surgery. J Thorac Cardiovasc Surg 64(5):826–830

    CAS  PubMed  Google Scholar 

  8. Prys Roberts C, Foex P, Biro GP, Roberts JG (1973) Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth 45(7):671–681

    Article  CAS  PubMed  Google Scholar 

  9. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L (1988) Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 68(4):495–500

    Article  CAS  PubMed  Google Scholar 

  10. Cole GD, Francis DP (2014) Perioperative beta blockade: guidelines do not reflect the problems with the evidence from the DECREASE trials. BMJ 349:g5210

    Article  PubMed  Google Scholar 

  11. Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Jensen G, Callesen T et al (2006) Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332(7556):1482–1485

    Article  PubMed  PubMed Central  Google Scholar 

  12. Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41(4):602–609

    Article  CAS  PubMed  Google Scholar 

  13. Yang H, Raymer K, Butler R, Parlow J, Roberts R (2006) The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152(5):983–990

    Article  CAS  PubMed  Google Scholar 

  14. Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C et al (2007) Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107(1):33–44

    Article  CAS  PubMed  Google Scholar 

  15. Auerbach AD, Goldman L (2002) Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 287(11):1435–1444

    CAS  PubMed  Google Scholar 

  16. Stevens RD, Burri H, Tramer MR (2003) Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 97(3):623–633

    Article  PubMed  Google Scholar 

  17. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE et al (2006) ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation 113(22):2662–2674

    Article  PubMed  Google Scholar 

  18. Blessberger H, Kammler J, Domanovits H, Schlager O, Wildner B, Azar D et al (2014) Perioperative beta-blockers for preventing surgery-related mortality and morbidity. Cochrane Database Syst Rev 9:CD004476.

    Google Scholar 

  19. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE et al (2009) 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 120(21):e169–e276

    Article  PubMed  Google Scholar 

  20. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G et al (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 30(22):2769–2812

    Article  PubMed  Google Scholar 

  21. Shammash JB, Trost JC, Gold JM, Berlin JA, Golden MA, Kimmel SE (2001) Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 141(1):148–153

    Article  CAS  PubMed  Google Scholar 

  22. Hoeks SE, Scholte Op Reimer WJ, van Urk H, Jorning PJ, Boersma E, Simoons ML et al (2007) Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. Eur J Vasc Endovasc Surg 33(1):13–19

    Article  CAS  PubMed  Google Scholar 

  23. Wallace AW, Au S, Cason BA (2010) Association of the pattern of use of perioperative beta-blockade and postoperative mortality. Anesthesiology 113(4):794–805

    Article  CAS  PubMed  Google Scholar 

  24. Fleisher LA, Poldermans D (2008) Perioperative beta blockade: where do we go from here? Lancet 371(9627):1813–1814

    Article  PubMed  Google Scholar 

  25. Poldermans D, Devereaux PJ (2009) The experts debate: perioperative beta-blockade for noncardiac surgery – proven safe or not? Cleve Clin J Med 76(Suppl 4):S84–S92 [Research Support, Non-U.S. Gov’t]

    Article  PubMed  Google Scholar 

  26. Sear JW, Giles JW, Howard-Alpe G, Foex P (2008) Perioperative beta-blockade, 2008: what does POISE tell us, and was our earlier caution justified? Br J Anaesth 101(2):135–138

    Article  CAS  PubMed  Google Scholar 

  27. Foex P, Sear JW (2014) II. Beta-blockers and cardiac protection: 5 yr on from POISE. Br J Anaesth 112(2):206–210

    Article  CAS  PubMed  Google Scholar 

  28. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G, Mitsakakis N et al (2010) Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology 112(1):25–33

    Article  PubMed  Google Scholar 

  29. Le Manach Y, Collins GS, Ibanez C, Goarin JP, Coriat P, Gaudric J et al (2012) Impact of perioperative bleeding on the protective effect of beta-blockers during infrarenal aortic reconstruction. Anesthesiology 117(6):1203–1211

    Article  PubMed  Google Scholar 

  30. Ragoonanan TE, Beattie WS, Mazer CD, Tsui AK, Leong-Poi H, Wilson DF et al (2009) Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats. Anesthesiology 111(5):988–1000

    Article  CAS  PubMed  Google Scholar 

  31. Center EM (2011) Erasmus MC dismisses professor. http://erasmusmc.nl/corp_home/corp_news-center/2011/2011-11/ontslag.hoogleraar/?lang=en

  32. Center EM (2012) Report of the 2012 follow-up investigation of possible breaches of academic integrity 2012. http://www.erasmusmc.nl/5663/135857/3675250/3706798/integrity_report_2012-10.pdf?lang=en&lang=en

  33. Poldermans D (2013) Scientific fraud or a rush to judgment? Am J Med 126(4):e5–e6 [Comment Letter]

    Article  PubMed  Google Scholar 

  34. Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP (2014) Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart 100(6):456–464 [Meta-Analysis Research Support, Non-U.S. Gov’t Review]

    Article  PubMed  PubMed Central  Google Scholar 

  35. Wijeysundera DN, Duncan D, Nkonde-Price C, Virani SS, Washam JB, Fleischer L; ACC/AHA Task force members (2014) Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130(24):2246–2264

    Google Scholar 

  36. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH (2008) Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 372(9654):1962–1976

    Article  CAS  PubMed  Google Scholar 

  37. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G (2008) Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 106(4):1039–1048

    Article  CAS  PubMed  Google Scholar 

  38. Biccard BM, Sear JW, Foex P (2008) Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. Br J Anaesth 100(1):23–28

    Article  CAS  PubMed  Google Scholar 

  39. Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ et al (2009) Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 249(6):921–926 [Comparative Study Meta-Analysis Randomized Controlled Trial Research Support, Non-U.S. Gov’t]

    Article  PubMed  Google Scholar 

  40. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B et al (2014) 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64(22):e77–e137

    Article  PubMed  Google Scholar 

  41. Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, Hert SD et al (2014) 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 35(35):2383–2431

    Article  PubMed  Google Scholar 

  42. Wijeysundera DN, Beattie WS, Wijeysundera HC, Yun L, Austin PC, Ko DT (2014) Duration of preoperative beta-blockade and outcomes after major elective noncardiac surgery. Can J Cardiol 30(2):217–223

    Article  PubMed  Google Scholar 

  43. Dai N, Xu D, Zhang J, Wei Y, Li W, Fan B et al (2014) Different beta-blockers and initiation time in patients undergoing noncardiac surgery: a meta-analysis. Am J Med Sci 347(3):235–244

    Article  PubMed  Google Scholar 

  44. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100(10):1043–1049

    Article  CAS  PubMed  Google Scholar 

  45. London MJ, Hur K, Schwartz GG, Henderson WG (2013) Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 309(16):1704–1713 [Research Support, Non-U.S. Gov’t]

    Article  CAS  PubMed  Google Scholar 

  46. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM (2005) Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353(4):349–361

    Article  CAS  PubMed  Google Scholar 

  47. Andersson C, Merie C, Jorgensen M, Gislason GH, Torp-Pedersen C, Overgaard C et al (2014) Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. JAMA Intern Med 174(3):336–344 [Research Support, Non-U.S. Gov’t]

    Article  CAS  PubMed  Google Scholar 

  48. Wallace AW, Au S, Cason BA (2011) Perioperative beta-blockade: atenolol is associated with reduced mortality when compared to metoprolol. Anesthesiology 114(4):824–836 [Comparative Study Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]

    Article  CAS  PubMed  Google Scholar 

  49. Ashes C, Judelman S, Wijeysundera DN, Tait G, Mazer CD, Hare GM et al (2013) Selective beta1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients. Anesthesiology 119(4):777–787

    Article  CAS  PubMed  Google Scholar 

  50. Guay J, Ochroch EA (2013) Beta-blocking agents for surgery: influence on mortality and major outcomes. A meta-analysis. J Cardiothorac Vasc Anesth 27(5):834–844

    Article  PubMed  Google Scholar 

  51. Kirsh MM, Behrendt DM, Jackson AP, Dhadphale P, Alseri S, Brymer J et al (1978) Myocardial revascularization in patients receiving long-term propranolol therapy. Ann Thorac Surg 25(2):117–121

    Article  CAS  PubMed  Google Scholar 

  52. Wechsler AS (1980) Assessment of prospectively randomized patients receiving propranolol therapy before coronary bypass operation. Ann Thorac Surg 30(2):128–136

    Article  CAS  PubMed  Google Scholar 

  53. Ponten J, Haggendal J, Milocco I, Waldenstrom A (1983) Long-term metoprolol therapy and neuroleptanesthesia in coronary artery surgery: withdrawal versus maintenance of beta 1-adrenoreceptor blockade. Anesth Analg 62(4):380–390

    CAS  PubMed  Google Scholar 

  54. Wan YD, Zhang SG, Sun TW, Kan QC, Wang LX (2014) The effects of perioperative beta-blockers on mortality in patients undergoing non-cardiac surgery in real world: a meta-analysis of cohort studies. Int J Cardiol 176(3):605–610

    Article  PubMed  Google Scholar 

  55. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507–520 [Research Support, N.I.H., Extramural]

    Article  CAS  PubMed  Google Scholar 

  56. Kelion AD, Banning AP (1999) Is simple clinical assessment adequate for cardiac risk stratification before elective non-cardiac surgery? Lancet 354(9193):1837–1838

    Article  CAS  PubMed  Google Scholar 

  57. Stone JG, Khambatta HJ, Sear JW, Foex P (2009) Beta-blockers: must we throw the baby out with the bath water? Anesth Analg 108(6):1987–1990

    Article  PubMed  Google Scholar 

  58. Oliver MF, Goldman L, Julian DG, Holme I (1999) Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 91(4):951–961

    Article  CAS  PubMed  Google Scholar 

  59. Wijeysundera DN, Naik JS, Beattie WS (2003) Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 114(9):742–752

    Article  CAS  PubMed  Google Scholar 

  60. Wallace AW, Galindez D, Salahieh A, Layug EL, Lazo EA, Haratonik KA et al (2004) Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 101(2):284–293

    Article  CAS  PubMed  Google Scholar 

  61. Devereaux PJ, Sessler DI, Leslie K, Kurz A, Mrkobrada M, Alonso-Coello P et al (2014) Clonidine in patients undergoing noncardiac surgery. N Engl J Med 370(16):1504–1513 [Research Support, Non-U.S. Gov’t]

    Article  CAS  PubMed  Google Scholar 

  62. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849–1860

    Article  PubMed  Google Scholar 

  63. Neilipovitz DT, Bryson GL, Nichol G (2001) The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 93(3):573–580

    Article  CAS  PubMed  Google Scholar 

  64. Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med 257(5):399–414

    Article  CAS  PubMed  Google Scholar 

  65. Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A et al (2014) Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370(16):1494–1503

    Article  CAS  PubMed  Google Scholar 

  66. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH et al (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380(9841):581–590

    Article  CAS  PubMed  Google Scholar 

  67. Ridker PM, Wilson PW (2013) A trial-based approach to statin guidelines. JAMA 310(11):1123–1124

    Article  CAS  PubMed  Google Scholar 

  68. Winchester DE, Wen X, Xie L, Bavry AA (2010) Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol 56(14):1099–1109

    Article  PubMed  Google Scholar 

  69. Chopra V, Wesorick DH, Sussman JB, Greene T, Rogers M, Froehlich JB et al (2012) Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis. Arch Surg 147(2):181–189 [Meta-Analysis Research Support, Non-U.S. Gov’t Review]

    Article  CAS  PubMed  Google Scholar 

  70. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM (2004) Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291(17):2092–2099

    Article  CAS  PubMed  Google Scholar 

  71. Kennedy J, Quan H, Buchan AM, Ghali WA, Feasby TE (2005) Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36(10):2072–2076

    Article  CAS  PubMed  Google Scholar 

  72. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B (2006) Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105(6):1260–1272; quiz 89–90

    Article  CAS  PubMed  Google Scholar 

  73. Desai H, Aronow WS, Ahn C, Gandhi K, Amin H, Lai HM et al (2010) Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins. Arch Gerontol Geriatr 51(2):149–151

    Article  PubMed  Google Scholar 

  74. Raju MG, Pachika A, Punnam SR, Gardiner JC, Shishehbor MH, Kapadia SR et al (2013) Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery. Clin Cardiol 36(8):456–461

    Article  PubMed  Google Scholar 

  75. Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P (2013) Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev 7:CD009971.

    Google Scholar 

  76. Wijeysundera DN, Beattie WS (2003) Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 97(3):634–641

    Article  CAS  PubMed  Google Scholar 

  77. Kertai MD, Westerhout CM, Varga KS, Acsady G, Gal J (2008) Dihydropiridine calcium channel blockers and perioperative mortality in aortic aneurysm surgery. Br J Anaesth 101(4):458–465

    Google Scholar 

  78. Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, LaBella M, Montori VM (2008) Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med 3(4):319–325

    Article  PubMed  Google Scholar 

  79. Turan A, You J, Shiba A, Kurz A, Saager L, Sessler DI (2012) Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery. Anesth Analg 114(3):552–560

    Article  CAS  PubMed  Google Scholar 

  80. Botto F, Alonso-Coello P, Chan MT, Villar JC, Xavier D, Srinathan S et al (2014) Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology 120(3):564–578

    Article  PubMed  Google Scholar 

  81. Devereaux PJ, Chan MT, Alonso-Coello P, Walsh M, Berwanger O, Villar JC et al (2012) Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 307(21):2295–2304 [Research Support, Non-U.S. Gov’t]

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuffield Division of Anaesthetics, University of Oxford, Oxford, UK

    Helen Higham & Pierre Foëx

Authors
  1. Helen Higham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre Foëx
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helen Higham .

Editor information

Editors and Affiliations

  1. Waimairi Anaesthesia Ltd, Christchurch, New Zealand

    Karen Stuart-Smith

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Higham, H., Foëx, P. (2016). Perioperative Beta-Blockade, the Pros and Cons. The Story of Beta-Blockade and Cardiac Protection. In: Stuart-Smith, K. (eds) Perioperative Medicine – Current Controversies. Springer, Cham. https://doi.org/10.1007/978-3-319-28821-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28821-5_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28819-2

  • Online ISBN: 978-3-319-28821-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation